BTA 0.00% 57.0¢ biota holdings limited

IceyRe the LANI deal - one would imagine that the product itself...

  1. 8,256 Posts.
    Icey

    Re the LANI deal - one would imagine that the product itself is seen as a market leader and cash cow. Therefore, hoping it will sell itself with some expert guidance on the maximising the up front dollars and royalties and importantly, the fine detail around performance and reporting.

    Looking at the Biota personnel, we have been paying one guy in the business development side of things for a while now - hope he is a gun negotiator:

    Dr Leigh Farrell was appointed Vice President, Business Development on 24 April 2006.

    Prior to joining Biota, Dr Farrell spent approximately 4 years as an Associate Director at GBS Ventures Partners Limited, a specialist Life Sciences Venture Capital Fund. Dr Farrell previously held the positions of Research Manager at Johnson & Johnson Research Pty Ltd and Chief Executive Officer of Gene Shears Pty Limited.

    Dr Farrell has extensive international experience in corporate finance, business development, licensing, relationship management and intellectual property portfolio management in the biotechnology and pharmaceutical industries. He is currently the Chairman of the Competitive Business Environment Working Group established under the 2007 Biotechnology Strategic Development Plan for Victoria.


    ...and then we have Peter Cook...
 
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.